| Literature DB >> 29942272 |
Angel Enrique1, Juana Bretón-López1,2, Guadalupe Molinari1, Pablo Roca3, Ginés Llorca4, Verónica Guillén5, Fernando Fernández-Aranda2,6, Rosa M Baños2,5, Cristina Botella1,2.
Abstract
Background: Positive psychological interventions (PPIs) have been suggested to produce benefits in patients with eating disorders (ED) by improving well-being, which might act as a buffer of the harmful effects caused by the disorder. Best Possible Self (BPS) is a PPI which consists of writing and envisioning a future where everything has turned out in the best possible way. In this regard, positive technology (PT) can be of considerable benefit as it allows to implement specific PPIs that have already shown efficacy. Objective: This study tested the preliminary efficacy of the BPS exercise implemented through a PT application and carried out for 1 month, in improving positive functioning measures, compared to a control condition, in patients with ED. Follow-up effects were also explored at 1 and 3 months later.Entities:
Keywords: affect; best possible self; eating disorders; optimistic thinking; positive psychological intervention; positive technology
Year: 2018 PMID: 29942272 PMCID: PMC6004415 DOI: 10.3389/fpsyg.2018.00934
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Descriptive data about demographic variables, diagnosis, functional impairment and medication.
| BPS condition | Control condition | Total sample | |
|---|---|---|---|
| Mean ( | 27.65 (9.00) | 26.44 (8.22) | 27.1 (8.60) |
| Male | 1 (3.4%) | 1 (4%) | 2 (3.7%) |
| Female | 28 (96.6%) | 24 (96%) | 52 (96.3%) |
| Single | 24 (82.8%) | 24 (96%) | 48 (88.9%) |
| Married | 3 (10.3%) | 1 (4%) | 4 (7.4%) |
| Divorced | 2 (6.9%) | 0 (0%) | 2 (3.7%) |
| Elementary school | 1 (3.4%) | 1 (4%) | 2 (3.7%) |
| High school | 10 (34.5%) | 12 (48%) | 22 (40.7%) |
| University degree | 18 (62.1%) | 12 (48%) | 30 (55.6%) |
| Anorexia nervosa | 4 (13.8%) | 5 (20%) | 9 (16.7%) |
| Bulimia nervosa | 7 (24.1%) | 4 (16%) | 11 (20.4%) |
| Binge eating disorder | 2 (6.9%) | 2 (8%) | 4 (7.4%) |
| EDNOS | 16 (55.2%) | 14 (56%) | 30 (55.6%) |
| Mild | 19 (65.5%) | 16 (64%) | 35 (64.8%) |
| Moderate | 9 (31%) | 8 (32% | 17 (31.5%) |
| Severe | 1 (3.4%) | 1 (4%) | 2 (3.7%) |
| No medication | 16 (55.2%) | 12 (48%) | 28 (51.9%) |
| Only anxiolytics | 0 (0%) | 1 (4%) | 1 (1.9%) |
| Only antidepressants | 2 (6.9%) | 1 (4%) | 3 (5.6%) |
| Only antiepileptics | 1 (3.4%) | 1 (4%) | 2 (3.7%) |
| Only antipsychothics | 0 (0%) | 0 (0%) | 0 (0%) |
| Combination of medications | 10 (34.5%) | 10 (40%) | 20 (37%) |
Means, standard deviations and within-group effect sizes for the outcome measures in the different time-point assessments.
| Mean ( | Within-group effect size, | Mean ( | Within-group effect size, | Within-group effect size, | ||||
|---|---|---|---|---|---|---|---|---|
| Pre | Post-training | Pre—post- training | 1st follow-up | 2nd follow-up | Pre—1st follow-up | Pre—2nd follow-up | ||
| SPT-POS | BPS | 4.03 (0.95) | 4.12 (1.44) | 0.09 [-0.32-0.50] | 4.67 (1.08) | 4.81 (1.17) | ||
| Control | 4.22 (1.20) | 4.37 (1.46) | 0.12 [-0.20-0.44] | 4.53 (1.42) | 4.84 (1.10) | |||
| Total | 4.12 (1.06) | 4.24 (1.45) | 4.60 (1.24) | 4.83 (1.13) | ||||
| SPT-NEG | BPS | 3.61 (1.31) | 2.84 (1.12) | 3.32 (1.42) | 3.07 (1.29) | 0.22 [-0.11–0.55] | ||
| Control | 3.35 (1.51) | 3.11 (1.60) | 0.15 [-0.04–0.35] | 3.30 (1.61) | 3.28 (1.61) | 0.03 [-0.18–0.24] | 0.04 [-0.15–0.23] | |
| Total | 3.49 (1.40) | 2.97 (1.35) | 3.31 (1.50) | 3.17 (1.44) | ||||
| PA | BPS | 2.57 (0.64) | 2.69 (0.98) | 0.18 [-0.12–0.49] | 2.94 (0.91) | 2.95 (0.96) | ||
| Control | 2.48 (0.86) | 2.79 (0.96) | 2.89 (1.15) | 2.99 (0.88) | ||||
| Total | 2.53 (0.74) | 2.74 (0.96) | 2.92 (1.02) | 2.97 (0.92) | ||||
| NA | BPS | 2.64 (1.00) | 2.29 (0.84) | 2.26 (0.98) | 2.19 (0.81) | |||
| Control | 2.48 (0.84) | 2.16 (0.91) | 2.27 (1.07) | 2.30 (1.07) | 0.24 [-0.06–0.55] | 0.21 [-0.08–0.50] | ||
| Total | 2.56 (0.93) | 2.23 (0.87) | 2.27 (1.01) | 2.24 (0.93) | ||||
| LOT-R | BPS | 18.24 (5.16) | 18.94 (4.55) | 0.13 [-0.24–0.5] | 19.27 (5.10) | 19.68 (5.27) | 0.19 [-0.04–0.43] | 0.27 [-0.01–0.55] |
| Control | 18.84 (5.31) | 18.23 (6.76) | -0.11 [-0.39–017] | 18.87 (6.84) | 19.49 (6.01) | 0.01 [-0.28–0.29] | 0.12 [-0.25–0.49] | |
| Total | 18.52 (5.19) | 18.61 (5.64) | 19.09 (5.92) | 19.59 (5.57) | ||||
| DHS | BPS | 40.58 (10.68) | 44.17 (9.31) | 0.33 [-0.02–0.67] | 43.76 (9.76) | 42.92 (11.78) | 0.29 [-0.03–0.61] | 0.21 [-0.09–0.52] |
| Control | 42.16 (13.32) | 42.89 (12.64) | 0.05 [-0.22–0.33] | 43.40 (11.77) | 43.84 (14.10) | 0.09 [-0.21–0.39] | 0.12 [-0.28–0.52] | |
| Total | 41.31 (11.88) | 43.58 (10.88) | 43.59 (10.63) | 43.35 (12.79) | ||||
| GSES | BPS | 39.71 (6.66) | 41.99 (6.94) | 41.76 (7.54) | 41.82 (7.54) | 0.30 [-0.09–0.69] | 0.31 [-0.06–0.67] | |
| Control | 37.12 (9.19) | 40.73 (10.16) | 39.63 (10.89) | 41.80 (7.81) | 0.14 [-0.14–0.41] | |||
| Total | 38.51 (7.97) | 41.40 (8.52) | 40.77 (9.21) | 41.81 (7.59) | ||||